This study tested whether low-dose naltrexone (LDN) can reduce fatigue and improve related symptoms in people with post-COVID fatigue syndrome. 160 adults who had confirmed COVID-19 and met criteria for post-COVID fatigue took either LDN or a placebo for 16 weeks. The main goal w…
Phase: PHASE2 • Sponsor: Luis Nacul • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC